List of works - Diana L. Noah

A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals

scientific article

Adapting global influenza management strategies to address emerging viruses

scientific article

Alanine substitutions within a linker region of the influenza A virus non-structural protein 1 alter its subcellular localization and attenuate virus replication ⬇️

scientific article published on April 20, 2011

Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS

scientific journal article

Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.

scientific article

Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1)

scientific article

Course of seasonal influenza A/Brisbane/59/07 H1N1 infection in the ferret

scientific article published on 9 July 2010

Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen

scientific article

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial

scientific article

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

scientific article published on March 2008

Efficient Translation of mRNAs in Influenza A Virus-Infected Cells Is Independent of the Viral 5′ Untranslated Region ⬇️

scientific article published on October 25, 2001

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans

scientific article published on February 2008

Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections ⬇️

scientific article published on September 18, 2012

Host gene expression signatures discriminate between ferrets infected with genetically similar H1N1 strains

scientific article

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

scientific article

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons

scientific article

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women

scientific article

Influenza exerts continued pressure in an era of modern medicine

scientific article published on 7 May 2009

Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species.

scientific article published on 13 July 2009

Influenza virus virulence and its molecular determinants

scientific article published in January 2005

Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures

scientific article

Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis

scientific article published on 01 June 2002

Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein

scientific article

Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant

scientific article

Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.

scientific article

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

scientific article

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

scientific article

Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.

scientific article

Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines

scientific article

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

scientific article

Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

scientific article

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults

scientific article

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant

scientific article

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial

scientific article published on October 2014

Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant

scientific article

The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.

scientific article

The Reovirus Protein μ2, Encoded by the M1 Gene, Is an RNA-Binding Protein ⬇️

scientific article published on October 1, 1998

List of works by Diana L. Noah

A cell-based luminescence assay is effective for high-throughput screening of potential influenza antivirals

Adapting global influenza management strategies to address emerging viruses

Alanine substitutions within a linker region of the influenza A virus non-structural protein 1 alter its subcellular localization and attenuate virus replication ⬇️

Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS

Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children.

Comparison of ribavirin and oseltamivir in reducing mortality and lung injury in mice infected with mouse adapted A/California/04/2009 (H1N1)

Course of seasonal influenza A/Brisbane/59/07 H1N1 infection in the ferret

Discovery of novel benzoquinazolinones and thiazoloimidazoles, inhibitors of influenza H5N1 and H1N1 viruses, from a cell-based high-throughput screen

Effect of Varying Doses of a Monovalent H7N9 Influenza Vaccine With and Without AS03 and MF59 Adjuvants on Immune Response: A Randomized Clinical Trial

Effects of adjuvants on the safety and immunogenicity of an avian influenza H5N1 vaccine in adults

Efficient Translation of mRNAs in Influenza A Virus-Infected Cells Is Independent of the Viral 5′ Untranslated Region ⬇️

Evaluation of the safety and immunogenicity of a booster (third) dose of inactivated subvirion H5N1 influenza vaccine in humans

Flagellin-HA vaccines protect ferrets and mice against H5N1 highly pathogenic avian influenza virus (HPAIV) infections ⬇️

Host gene expression signatures discriminate between ferrets infected with genetically similar H1N1 strains

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

Immunogenicity and safety of varying dosages of a monovalent 2009 H1N1 influenza vaccine given with and without AS03 adjuvant system in healthy adults and older persons

Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women

Influenza exerts continued pressure in an era of modern medicine

Influenza virus M2 protein inhibits epithelial sodium channels by increasing reactive oxygen species.

Influenza virus virulence and its molecular determinants

Interferon regulatory factor 3 is required for viral induction of beta interferon in primary cardiac myocyte cultures

Interferon regulatory factor-1, interferon-beta, and reovirus-induced myocarditis

Intracellular warfare between human influenza viruses and human cells: the roles of the viral NS1 protein

Persistence of Antibody to Influenza A/H5N1 Vaccine Virus: Impact of AS03 Adjuvant

Phase 2 assessment of the safety and immunogenicity of two inactivated pandemic monovalent H1N1 vaccines in adults as a component of the U.S. pandemic preparedness plan in 2009.

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

Point-of-Use Mixing of Influenza H5N1 Vaccine and MF59 Adjuvant for Pandemic Vaccination Preparedness: Antibody Responses and Safety. A Phase 1 Clinical Trial

Qualification of the hemagglutination inhibition assay in support of pandemic influenza vaccine licensure.

Retinoic acid inducible gene-I and mda-5 are involved in influenza A virus-induced expression of antiviral cytokines

Safety and immune responses in children after concurrent or sequential 2009 H1N1 and 2009-2010 seasonal trivalent influenza vaccinations

Safety and immunogenicity of an inactivated influenza A/H5N1 vaccine given with or without aluminum hydroxide to healthy adults: results of a phase I-II randomized clinical trial.

Safety and immunogenicity of inactivated, Vero cell culture-derived whole virus influenza A/H5N1 vaccine given alone or with aluminum hydroxide adjuvant in healthy adults

Safety, Reactogenicity, and Immunogenicity of Inactivated Monovalent Influenza A(H5N1) Virus Vaccine Administered With or Without AS03 Adjuvant

Serological responses to an avian influenza A/H7N9 vaccine mixed at the point-of-use with MF59 adjuvant: a randomized clinical trial

Technology transfer of oil-in-water emulsion adjuvant manufacturing for pandemic influenza vaccine production in Romania: Preclinical evaluation of split virion inactivated H5N1 vaccine with adjuvant

The CPSF30 binding site on the NS1A protein of influenza A virus is a potential antiviral target.

The Reovirus Protein μ2, Encoded by the M1 Gene, Is an RNA-Binding Protein ⬇️